Abstract:Schistosomiasis is a serious and neglected disease with a high prevalence in tropical and subtropical countries. The primary pathology of hepatic schistosomiasis caused by Schistosoma japonicum ( S . japonicum ) or Schistosoma mansoni ( S . mansoni ) infection is egg-induced granuloma and subsequent fibrosis in the liver. Activation of hepatic stellate cells (HSCs) is the central driver of liver fibrosis. Macrophages (Mφ), making up 30% of cells in hepatic granulomas, directly or indirectly regulate HSC activation by paracrine mechanisms, via secreting cytokines or chemokines. Currently, Mφ-derived extracellular vesicles (EVs) are broadly involved in cell communication with adjacent cell populations. However, whether Mφ-derived EVs could target neighboring HSCs to regulate their activation during schistosome infection remains largely unknown. Schistosome egg antigen (SEA) is considered to be the main pathogenic complex mixture involved in liver pathology. Here, we demonstrated that SEA induced Mφ to produce abundant extracellular vesicles, which directly activated HSCs by activating their autocrine TGF-β1 signaling. Mechanistically, EVs derived from SEA-stimulated Mφ contained increased miR-33, which were transferred into HSCs and subsequently upregulated autocrine TGF-β1 in HSCs through targeting and downregulating SOCS3 expression, thereby promoting HSC activation. Finally, we validated that EVs derived from SEA-stimulated Mφ utilized enclosed miR-33 to promote HSC activation and liver fibrosis in S . japonicum -infected mice. Overall, our study indicates that Mφ-derived EVs play important roles in the paracrine regulation of HSCs during the progression of hepatic schistosomiasis, representing a potential target for the prevention of liver fibrosis in hepatic schistosomiasis. Schistosomiasis is a neglected parasitic disease affecting over 250 million people in tropical and subtropical regions. Among the common pathogenic species, Schistosoma japonicum and Schistosoma mansoni mainly cause hepatic schistosomiasis, which is mainly attributed to liver-trapped schistosome eggs, leading to granulomatous inflammation and liver fibrosis. HSC activation is the central driver of liver fibrosis during hepatic schistosomiasis. Macrophages (Mφ) are tightly connected to HSC activity. Currently, much evidence supports the pivotal role of Mφ-derived extracellular vesicles (EVs). However, the potential involvement of Mφ-derived EVs in HSC communication and modulation in hepatic schistosomiasis remains largely unknown. In this study, the authors illustrate that S . japonicum infection utilizes Mφ-derived EVs to promote HSC activation and liver fibrosis. Briefly, schistosome egg antigen (SEA) induces Mφ to secrete abundant miR-33-enriched EVs, which are transferred to enhance autocrine TGF-β1 production by targeting SOCS3 in HSCs, thereby promoting HSC activation and liver fibrosis. These discoveries provide a previously unrecognized Mφ-EVs-based therapeutic target regarding HSC activation, which can be manipulated to prevent liver fibrosis during hepatic schistosomiasis.

MicroR-146 blocks the activation of M1 macrophage by targeting signal transducer and activator of transcription 1 in hepatic schistosomiasis.

MicroRNA-96 Promotes Schistosomiasis Hepatic Fibrosis in Mice by Suppressing Smad7

Down-regulation of Microrna-203-3p Initiates Type 2 Pathology During Schistosome Infection Via Elevation of Interleukin-33

Activation of Nuclear Factor Kappa B in the Hepatic Stellate Cells of Mice with Schistosomiasis Japonica.

MicroRNA-351 Promotes Schistosomiasis-Induced Hepatic Fibrosis by Targeting the Vitamin D Receptor

Induction of hepatic fibrosis in mice with schistosomiasis by extracellular microRNA-30 derived from Schistosoma japonicum eggs

A MicroRNA Derived from Schistosoma Japonicum Promotes Schistosomiasis Hepatic Fibrosis by Targeting Host Secreted Frizzled-Related Protein 1

Recombinant Adeno‐associated Virus–mediated Inhibition of Microrna‐21 Protects Mice Against the Lethal Schistosome Infection by Repressing Both IL‐13 and Transforming Growth Factor Beta 1 Pathways

A schistosome miRNA promotes host hepatic fibrosis by targeting transforming growth factor beta receptor III

Schistosome egg antigen stimulates the secretion of miR-33-carrying extracellular vesicles from macrophages to promote hepatic stellate cell activation and liver fibrosis in schistosomiasis

MicroRNA-146b Regulates Hepatic Stellate Cell Activation Via Targeting of KLF4.

Hepatocyte CD1d Protects Against Liver Immunopathology in Mice with Schistosomiasis Japonica.

Activation of Primary Hepatic Stellate Cells and Liver Fibrosis Induced by Targeting TGF-β1/Smad Signaling in Schistosomiasis in Mice

MicroRNA-29a-3p Prevents Schistosoma Japonicum -Induced Liver Fibrosis by Targeting Roundabout Homolog 1 in Hepatic Stellate Cells

Upregulation of KSRP by Mir‐27b Attenuates Schistosomiasis‐induced Hepatic Fibrosis by Targeting TGF‐β1

MicroRNA Expression Profile in Different Tissues of BALB/c Mice in the Early Phase of Schistosoma Japonicum Infection

miR-182-5p attenuates <italic>Schistosoma japonicum</italic>-induced hepatic fibrosis by targeting tristetraprolin

MicroRNA 200a inhibits liver fibrosis of schistosoma

Retracted: MicroRNA‐29b‐3p Prevents Schistosoma Japonicum‐induced Liver Fibrosis by Targeting COL1A1 and COL3A1

MiR-130a-3p Alleviates Liver Fibrosis by Suppressing HSCs Activation and Skewing Macrophage to Ly6Clo Phenotype

MiR-130a-3p Alleviates Liver Fibrosis by Suppressing HSCs Activation and Skewing Macrophage to Ly6C<SUP>lo</SUP> Phenotype